And some researchers hoped that the drugs could also help with some of the most difficult diseases to treat — those of the brain, like Parkinson’s. But now, at least for Parkinson’s ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease. The US FDA this week approved the sale of the treatment, which ...

The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, finds a new study led by UCL researchers. The world's largest and longest ...

It is hoped the free course will be accessed by people around the world and improve awareness and understanding of Parkinson's Disease to help those living with it, as well as health professionals ...

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

A word. A sentence. A fate. Mine? Parkinson’s, the P word. It arises unbidden as I walk, my left leg not quite keeping pace with my right. It floats to top of mind when my tremor flares in a ...

Jan. 14, 2025 — There may be a link between hearing impairment and an increased risk of developing Parkinson's according to new research. This is one of the first studies to examine whether ...

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s disease ONAPGO is a wearable subcutaneous ...

The act establishes a Federal Advisory Council on Parkinson's Research, Care, and Services and calls for the creation and regular updating of a national plan to prevent, diagnose, treat ...

Delray Medical Center cut the ribbon on its newest high-tech machine last week that targets brain areas to treat movement disorders such as essential tremor and tremor-dominant Parkinson’s disease.

Get Instant Summarized Text (Gist) A key regulator for the GTPase function of the LRRK2 gene, linked to Parkinson's Disease, has been identified. This regulator, CalDAG-GEFI, can control the ...

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify biomarkers of Parkinson’s disease well in advance of symptoms appearing.